Looking to Partner with Companies Developing Small Molecule & Protein Degradation Therapeutics Across a Range of Undrugged or Hard-to-Drug Targets?
We partner with cutting-edge solution and service providers with small molecule specific capabilities in structural biology, medicinal chemistry, pre-clinical and clinical development, with the goal to assist the industry to overcome existing challenges to further progress in this emerging field to address unmet patient needs.
If you have relevant capabilities in this space and would like to align your brand with the small molecules and protein degradation community, contact us to promote your capabilities through a bespoke commercial package.
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.
Download Your Copy of the Sponsorship Prospectus
Explore the Agenda
Hear the latest breakthroughs in throughput, coverage, and sensitivity of proteomics methodologies, uncover data-driven presentations, and engage in panel discussions on translating large-scale proteomics data into meaningful drug discovery conclusions.
Partner With Us
Position yourself alongside other proteomics, mass spectrometry and data analysis solution providers, demonstrating your capabilities and increasing your brand awareness to a room full of proteomics decision makers.
Join Biopharma Experts
Be part of cutting-edge discussions with fellow proteomics pioneers to transform drug discovery across a range of modalities, whether you’re working on TPD, ADCs, small molecules, or beyond.